Maximum quantity allowed is 999
CAS RN: 19171-19-8 | Product Number: P2074
Pomalidomide
Purity: >98.0%(HPLC)
- 3-Amino-N-(2,6-dioxo-3-piperidyl)phthalimide
Size | Unit Price | Hyderabad | Japan* | Quantity |
---|---|---|---|---|
25MG |
₹9,800.00
|
1 | ≥60 |
|
100MG |
₹14,500.00
|
1 | ≥100 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | P2074 |
Purity / Analysis Method | >98.0%(HPLC) |
Molecular Formula / Molecular Weight | C__1__3H__1__1N__3O__4 = 273.25 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Refrigerated (0-10°C) |
Condition to Avoid | Heat Sensitive |
Packaging and Container | 100MG-Glass Bottle with Plastic Insert (View image), 25MG-Glass Bottle with Plastic Insert (View image) |
CAS RN | 19171-19-8 |
Reaxys Registry Number | 8340987 |
PubChem Substance ID | 253660183 |
Merck Index (14) | 135 |
MDL Number | MFCD12756407 |
Appearance | White to Yellow to Green powder to crystaline |
Purity(HPLC) | min. 98.0 area% |
Melting Point | 313 °C(dec.) |
Pictogram | |
Signal Word | Warning |
Hazard Statements | H361 : Suspected of damaging fertility or the unborn child. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P405 : Store locked up. |
RTECS# | NR3397905 |
References
- Protective antitumor immunity induced by a costimulatory thalidomide analog in conjunction with whole tumor cell vaccination is mediated by increased Th1-type immunity
- Lenalidomide and CC-4047 Inhibit the Proliferation of Malignant B Cells while Expanding Normal CD34+ Progenitor Cells
- The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells
- Pharmacological properties of thalidomide and its analogues
- Pomalidomide therapy for myeloma
- Molecular mechanism of action of immune-modulatory drugs thalidomide, lenalidomide and pomalidomide in multiple myeloma
Articles/Brochures
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.